Acadia Pharmaceuticals Archives -

Acadia Pharma’s attempts to extend the indications of its Nuplazid drug in the US to include Alzheimer’s disease-related

FDA panel turns down Acadia’s Nuplazid for Alzheimer’s psychosis

https://pharmaphorum.com/news/fda-panel-turns-down-acadias-nuplazid-for-alzheimers-psychosis/

Acadia Pharma’s trofinetide has hit its efficacy targets in a phase 3 trial involving girls with the devastating

Acadia closer to bringing first Rett syndrome drug to market

https://pharmaphorum.com/news/acadia-closer-to-bringing-first-rett-syndrome-drug-to-market/

The unexpected approval and lofty pricing of Biogen’s Alzheimer’s therapy Aduhelm is clearly the biopharma event of the

Aduhelm approval could signal new era for CNS drugs; analysts

https://pharmaphorum.com/news/aduhelm-approval-could-signal-new-era-for-cns-drugs-analysts/

FDA under pressure to act following press reports

FDA probes Parkinson’s drug safety, Acadia’s shares collapse

https://pharmaphorum.com/news/fda-probes-parkinsons-drug-safety-acadias-shares-collapse/

CNN report raises safety concerns

Acadia shares hit by media doubts over Parkinson’s drug

https://pharmaphorum.com/news/acadia-shares-hit-media-doubts-parkinsons-drug/

Acadia Pharmaceuticals